Abstract
SMAD proteins are phosphorylated by transforming growth factor-beta (TGF-beta) receptors and translocate to the nucleus, where they control transcription. Here we investigate the fate of activated Smad2. We show that receptor-mediated activation leads to multi-ubiquitination and subsequent degradation of Smad2 by the proteasome. Ubiquitination of Smad2 is a consequence of its accumulation in the nucleus. If degradation is averted, the phosphorylated Smad2 remains in the nucleus in an active state. By targeting Smad2 for destruction, TGF-beta ensures the irreversible termination of its own signalling function.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Cell Line
-
Cell Nucleus / drug effects
-
Cell Nucleus / enzymology
-
Cell Nucleus / metabolism
-
Cysteine Endopeptidases / metabolism
-
DNA-Binding Proteins / genetics
-
DNA-Binding Proteins / metabolism*
-
Fluorescent Antibody Technique
-
Half-Life
-
Humans
-
Models, Biological
-
Multienzyme Complexes / antagonists & inhibitors
-
Multienzyme Complexes / metabolism
-
Phosphorylation / drug effects
-
Proteasome Endopeptidase Complex
-
Protein Processing, Post-Translational / drug effects*
-
Signal Transduction / drug effects
-
Smad2 Protein
-
Trans-Activators / genetics
-
Trans-Activators / metabolism*
-
Transfection
-
Transforming Growth Factor beta / pharmacology*
-
Ubiquitins / metabolism*
Substances
-
DNA-Binding Proteins
-
Multienzyme Complexes
-
SMAD2 protein, human
-
Smad2 Protein
-
Trans-Activators
-
Transforming Growth Factor beta
-
Ubiquitins
-
Cysteine Endopeptidases
-
Proteasome Endopeptidase Complex